Drug intelligence / Profile preview

morphine + promethazine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Intravenous
01

Overview

Morphine and promethazine combination is used for pain management, particularly in pre-operative and post-operative settings. This combination leverages promethazine's ability to enhance morphine's analgesic effects while potentially allowing for lower opioid doses. Morphine is a narcotic analgesic that acts on the central nervous system to relieve pain. Promethazine is a first-generation antihistamine with multiple effects, including antihistaminic, sedative, anti-motion sickness, and antiemetic properties. When used together, promethazine improves relief of anxiety, sedation, and patient acceptance compared to morphine alone. The combination has been noted to have an opioid-sparing effect, allowing for lower doses of opioids to achieve sedation and analgesia. However, consuming large quantities of these two drugs together can intensify each drug's sedative effects and increase the risk of life-threatening events, including delirium, respiratory depression, overdose, neuroleptic malignant syndrome, and QT interval prolongation. In contemporary medical practice, the use of these drugs in combination for sedation has declined due to these adverse effects and lack of data supporting clinical efficacy. Nevertheless, promethazine has been found in fatal opioid overdoses, indicating continued combined use outside medical settings.

Brand names
Mepergan
Other names
Morphine-Promethazine
02

Targets

DOR (Opioid Receptor Delta 1)HRH1 (Histamine H1 Receptor)KOR (Kappa opioid receptor)mAChR (Muscarinic acetylcholine receptors)MOR (Mu opioid receptor)AR (Adrenergic receptors)DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on morphine + promethazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + promethazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call